About Us
We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology – enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation – enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on LinkedIn
About the Role
The Regulatory Information Manager will support the development of traceable systems, processes, and tools used to collect, manage, and track regulatory information and data throughout the lifecycle of Dianthus products, and oversee the management of all data related to regulatory matters. The successful candidate will help ensure a centralized, structured approach to regulatory submissions compliance with global authority commitments and expectations, and support inspection readiness.
You will serve as a critical link between regulatory affairs and the rest of R&D to ensure that information, such as the status of submissions and knowledge gained from previous health authority queries, is accurate and up to date to support strategic decision-making.
This is a unique opportunity to join a growing organization with an expanding pipeline, and to play an integral role in the in the global development of all programs. We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients’ lives. We are open to you working remotely.
Key Responsibilities
Experience

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.